TScan Therapeutics Inc (TCRX)
NASDAQ
Quarter End | 9 2022 | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||||
総資産 | 165.45M | 199.09M | 173.58M | 316.92M | 291.38M | 272.15M | 240.83M | 374.87M |
流動資産合計 | 141.18M | 124.13M | 100.91M | 242.22M | 217.57M | 194.24M | 164.72M | 299.53M |
現金および同等物 | 137.31M | 120.03M | 95.61M | 208.84M | 155.19M | 133.36M | 140.51M | 242.16M |
非流動資産合計 | 24.28M | 85.06M | 72.67M | 74.71M | 73.81M | 85.65M | 76.11M | 75.34M |
負債合計 | 48.8M | 99.66M | 95.56M | 126.32M | 122.42M | 121.28M | 117.87M | 119.65M |
流動負債合計 | 16.59M | 17.31M | 14.05M | 35.12M | 33.15M | 29.82M | 31.48M | 38.57M |
非流動負債合計 | 61.28M | 111.64M | 111.02M | 120.92M | 118.1M | 118.16M | 109.84M | 101.19M |
普通株 | 3k | 3k | 3k | 5k | 5k | 5k | 5k | 6k |
留保所得 | -139.66M | -158.38M | -180.94M | -204.99M | -227.98M | -247.6M | -277.74M | -309.4M |
年末 2023年12月31日 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総資産 | 49.38M | 49.74M | 188.11M | 199.09M | 272.15M |
流動資産合計 | 42.38M | 36.45M | 165.65M | 124.13M | 194.24M |
現金および同等物 | 41.76M | 34.79M | 161.41M | 120.03M | 133.36M |
非流動資産合計 | -17.14M | -42.46M | 160.78M | 99.43M | 150.87M |
負債合計 | 6.84M | 32.52M | 27.33M | 99.66M | 121.28M |
流動負債合計 | 2.4M | 17.45M | 21.34M | 17.31M | 29.82M |
非流動負債合計 | 4.44M | 15.07M | 5.99M | 111.64M | 118.16M |
総資本 | -17.14M | -42.46M | 160.78M | 99.43M | 150.87M |
普通株 | 0 | 1,000 | 3k | 3k | 5k |
留保所得 | -17.41M | -43.53M | -92.16M | -158.38M | -247.6M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約